Patients with intracranial bleeding and atrial fibrillation treated with left atrial appendage occlusion: Results from the Amplatzer Cardiac Plug registry.

Tzikas, Apostolos; Freixa, Xavier; Llull, Laura; Gafoor, Sameer; Shakir, Samera; Omran, Heyder; Giannakoulas, George; Berti, Sergio; Santoro, Gennaro; Kefer, Joelle; Aminian, Adel; Gloekler, Steffen; Landmesser, Ulf; Nielsen-Kudsk, Jens Erik; Cruz-Gonzalez, Ignacio; Kanagaratnam, Prapa; Nietlispach, Fabian; Ibrahim, Reda; Sievert, Horst; Schillinger, Wolfgang; ... (2017). Patients with intracranial bleeding and atrial fibrillation treated with left atrial appendage occlusion: Results from the Amplatzer Cardiac Plug registry. International journal of cardiology, 236, pp. 232-236. Elsevier 10.1016/j.ijcard.2017.02.042

[img] Text
Patients with intracranial....pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (468kB) | Request a copy

BACKGROUND In patients with non-valvular atrial fibrillation (NVAF), intracranial bleeding (ICB) constitutes a very challenging situation in which the rate of both ischemic and hemorrhagic events is increased. In these patients, left atrial appendage occlusion (LAAO) might represent a very valid alternative. OBJECTIVES To investigate the procedural safety and long-term outcome of patients undergoing LAAO therapy due to previous ICB. METHODS Data from the Amplatzer Cardiac Plug multicenter registry on 1047 consecutive patients were analyzed. Patients with previous ICB as indication for LAAO were compared to patients with other indications. RESULTS A total of 198 patients (18.9%) with previous ICB were identified. The CHA2DS2-VASc score was similar (4.5±1.5 vs. 4.4±1.6, p=0.687) and the HAS-BLED score was higher in patients with previous ICB compared to those without (3.5±1.1 vs. 3.1±1.2, p<0.001). No significant differences in peri-procedural major adverse events were observed (2.5 vs 5.4%, p=0.1). Patients with previous ICB were more frequently on single acetylsalicylic acid therapy after LAAO (42.4% vs. 28.3%; p<0.001). With an average follow-up of 1.3years, the observed annual stroke/TIA rate (procedure and follow-up) for patients with previous ICB was 1.4% (75% relative risk reduction). The observed annual major bleeding rate (procedure and follow-up) for patients with previous ICB was 0.7% (89% relative risk reduction). CONCLUSIONS In patients with NVAF and previous ICB, LAAO seemed to be a safe procedure and was associated with a significant reduction in stroke/TIA and a remarkably low frequency of major bleeding during follow-up.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Meier, Bernhard

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0167-5273

Publisher:

Elsevier

Language:

English

Submitter:

Luana Cauto

Date Deposited:

27 Feb 2018 09:27

Last Modified:

27 Oct 2019 07:45

Publisher DOI:

10.1016/j.ijcard.2017.02.042

PubMed ID:

28215464

Uncontrolled Keywords:

Device LAA closure Prevention Stroke

BORIS DOI:

10.7892/boris.111213

URI:

https://boris.unibe.ch/id/eprint/111213

Actions (login required)

Edit item Edit item
Provide Feedback